Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
FDA panel recommends approval of telaprevir for hepatitis C.
FDA: Although tests revealed side effects such as anemia and rashes, the panel praised the drug’s apparent 80 percent cure rate for the virus, up from 40 percent for current treatments.